Senior Vice President and General Counsel, Eli Lilly and Company
Prior to joining Lilly, Anat served as executive vice president, general counsel and secretary, for WellCare Health Plans, Inc. (WCG). Before joining WellCare, Anat served as global divisional vice president, associate general counsel for litigation, for Abbott Laboratories. In an earlier role at Abbott, Anat served as divisional vice president, associate general counsel for intellectual property litigation. She has deep and broad experience in global matters, including the Foreign Corrupt Practices Act; bet-the-company commercial, patent and trademark litigation; mergers and acquisitions; significant internal and government investigations; whistleblower lawsuits; and securities litigation.
Before going in-house, Anat spent 17 years at two global law firms – Foley & Lardner, LLP, where she was an equity partner in the patent litigation group, and Latham & Watkins, as an associate in the securities and financial fraud litigation group.
Anat received her bachelor of arts degree in 1990 from the University of Wisconsin. She received her law degree from Harvard Law School in 1993.
In 2019, Anat was honored by the American Lawyer, receiving the prestigious General Counsel of the Year Award. Earlier that year, Anat was also named to The Legal 500 GC Powerlist, which recognizes the nation’s most influential and innovative general counsel. She and her team at WellCare were also honored by the Daily Business Review, Florida’s leading legal publication, as the 2019 Florida Legal Department of the Year.
From 2017 to 2019, Anat served on the Florida Federal Judicial Nominating Commission, Southern District, for the 115th Congress, to which she was appointed by U.S. senators Marco Rubio and Bill Nelson. The commission is responsible for selecting, interviewing and recommending federal district court judge applicants to Florida’s two senators and the president.